Psychopharmacology of schizophrenia

C Lalasa; S Nazneen Sultana; D Hepcy Kalarani

doi:10.33545/27067009.2021.v3.i2a.88

Psychopharmacology of schizophrenia

Author(s):

C Lalasa, S Nazneen Sultana and D Hepcy Kalarani

Abstract:

The revolution in psychopharmacology and biological psychiatry started by the introduction of chlorpromazine provided the first effective treatment for schizophrenia, as well as ideas and evidence about the pathophysiology of the illness. Brain imaging studies of receptor densities in young adults and children, or in patients with first-episode schizophrenia may be helpful in identifying early vulnerability factors.

DOI: 10.33545/27067009.2021.v3.i2a.88

Pages: 28-30 | 608 Views 195 Downloads

Download (578KB)

International Journal of Pharmacognosy and Pharmaceutical Sciences

How to cite this article:

C Lalasa, S Nazneen Sultana and D Hepcy Kalarani. Psychopharmacology of schizophrenia. Int. J. Pharmacognosy Pharm. Sci. 2021;3(2):28-30. DOI: 10.33545/27067009.2021.v3.i2a.88

Vol. 3, Issue 2, Part A (2021)

Psychopharmacology of schizophrenia